Recombinant Mouse RTN4R Protein, N-His from ProteoGenix; catalogue ARO-P11040; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Recombinant Mouse RTN4R Protein is a highly purified protein that is produced through recombinant DNA technology. It is a member of the reticulon family of proteins, which are involved in various cellular processes such as membrane trafficking, endoplasmic reticulum (ER) function, and axonal regeneration. This protein has been extensively studied and has shown promising results in various applications.
The Recombinant Mouse RTN4R Protein is a transmembrane protein with a molecular weight of approximately 55 kDa. It contains a N-terminal cytoplasmic domain, a transmembrane domain, and a C-terminal extracellular domain. The extracellular domain contains three conserved domains: a hydrophobic region, a large loop, and a C-terminal tail. These domains are important for the protein’s function and interactions with other molecules.
The main activity of the Recombinant Mouse RTN4R Protein is its role in axonal regeneration. It is a receptor for the myelin-associated inhibitor, Nogo, which is a protein that inhibits axonal growth. When Nogo binds to RTN4R, it activates downstream signaling pathways that inhibit axonal regeneration. However, when the Recombinant Mouse RTN4R Protein is used, it acts as a competitive inhibitor, preventing Nogo from binding to the endogenous RTN4R and thus promoting axonal regeneration.
In addition to its role in axonal regeneration, the Recombinant Mouse RTN4R Protein has also been shown to play a role in ER function. It is involved in the formation and maintenance of the ER network, as well as the regulation of ER stress response. This protein has also been linked to the regulation of autophagy, a cellular process involved in the degradation of damaged or unnecessary cellular components.
The Recombinant Mouse RTN4R Protein has various applications in both research and therapeutic settings. Its most well-known application is in promoting axonal regeneration, making it a potential treatment for spinal cord injuries and other neurological disorders. It has also been studied for its potential in treating neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Furthermore, the Recombinant Mouse RTN4R Protein has been used in research to study its role in cellular processes such as ER function and autophagy. It has also been used to investigate the mechanisms of axonal regeneration and the potential of other molecules to promote or inhibit this process.
The Recombinant Mouse RTN4R Protein is a crucial protein involved in axonal regeneration and other cellular processes. Its structure, activity, and applications make it a valuable tool in both research and therapeutic settings. With further studies and advancements in technology, this protein has the potential to greatly impact the treatment of neurological disorders and contribute to a better understanding of cellular processes.
ProteoGenix catalogue number ARO-P11040. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 34.06 kDa; Fragment: Thr25-Gly308; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
